MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
Shield Therapeutics
Parents
*Architects: BioPharmaceutical Drug Discovery & Development (Miscellaneous)
*Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
*Industry: United Kingdom - UK (England, Scotland, Wales, Northern Ireland)
Venture Capital: Series A
Children
developer and commercializer of late-stage hospital pharmaceuticals, has raised €8.2 million in Series A funding from Inventages Venture Capital (2011)
London, England, United Kingdom
Participants include Inventages Venture Capital.
Series A $12M by OnBioVC (2011)